On June 9, 2025, Cabaletta Bio, Inc. held its Annual Meeting and approved an amendment to double its authorized shares from 150 million to 300 million, along with electing directors and ratifying its accounting firm. The meeting confirmed 50,743,101 outstanding shares as of May 12, 2025.